PA-AL Clinical Trial

A new anti-malarial Artemisinin-based combination drug, pyronadine-artesunate, has been registered and we are carrying out a randomized controlled clinical trial to compare it's efficacy, safety and effects on transmission of malaria against the recommended first-line drug, Artemether lumefantrine.

Funding:

• European Union

Collaborators:

• The Royal Tropical Insitute, KIT, Amsterdam